{Reference Type}: Case Reports
{Title}: Infantile inflammatory bowel disease in three Syrian infants: a case series.
{Author}: Alshwaiki A;Samir Nakhal RMHD;Nahle AA;Hamdar H;Martini N;Mahmod J;
{Journal}: J Med Case Rep
{Volume}: 18
{Issue}: 1
{Year}: 2024 Mar 18
暂无{DOI}: 10.1186/s13256-024-04456-9
{Abstract}: <B>BACKGROUND: </B>Inflammatory bowel diseases, consisting of Crohn's disease and ulcerative colitis, are chronic bowel relapsing inflammatory disorders. Inflammatory bowel diseases begin rarely in infants. Approximately 25% of patients with inflammatory bowel diseases present before the age of 20 years. Very early-onset inflammatory bowel disease occurs before the age of 6 years; infantile inflammatory bowel diseases occurs before the age of 2 years, and is extremely rare in infants under 1 year of age.<BR><B>METHODS: </B>Herein, we report a case series of 7-month-, 11-month-, and 12-month-old Syrian infants that presented with diarrhea, hematochezia, and pale appearance and were finally diagnosed with infantile inflammatory bowel disease and treated.<BR><B>CONCLUSIONS: </B>Early diagnosis and ruling out infantile inflammatory bowel diseases despite its rarity are recommended. Over and above that, new drugs such as vedolizumab, golimumab, and less invasive treatment methods should also be taken into consideration for better response and adequate remission with improved quality of life.